Originally published at FamousIntel.com
Vasant Narasimhan Biography and Wiki
Vasant Narasimhan is an Indian-American physician and the CEO of Novartis. He is the CEO of a business with approximately 100,000 employees that operates in more than 150 countries and provides medicines to 766 million patients in 2021.
Vasant Narasimhan Education
Narasimhan graduated from the University of Chicago with a bachelor’s degree in biological sciences, from Harvard Medical School with a medical degree, and from the John F. Kennedy School of Government with a master’s degree in public policy.
Vasant Narasimhan Age and Birthday
Narasimhan is 46 years old as of 2022. She was born Vasant “Vas” Narasimhan on 26 August 1976 in Pittsburgh, Pennsylvania, United States of America. He celebrates his birthday on 26 August every year.
Vasant Narasimhan Nationality & Ethnicity
Is Vasant Narasimhan Indian? Narasimhan is of American nationality by birth. He was born in Pittsburgh, Pennsylvania, United States. He was born to Indian diaspora. Also read: Oscar Munoz
Vasant Narasimhan Family
Narasimhan was born to Kalathur Narasimhan and Geeta Narasimhan. Geeta Narasimhan, a former nuclear engineer for Public Service Electric and Gas, is now a physics lecturer at Burlington County Community College in Pemberton, New Jersey. Hoeganaes Corporation, a developer and supplier of industrial raw materials, in Cinnamon, New Jersey, appoints his father as vice president for research and development.
vasant narasimhan wife
Narasimhan was married to Dr. and Mrs. Jagdish K. Gupta is born to Srishi Gupta, daughter of Roslyn, NY. The couple married at Antun Kettering in Hicksville, NY
Vasant Narasimhan Height
The average height of Narasimhan is 6 feet 0 inches.
What is the salary of Novartis CEO?
The total actual salary of CEO in 2021 was CHF 11 224 727.
Vasant Narasimhan net worth
Narasimhan has an estimated net worth of $5 million.
Vasant Narasimhan Novartis
After graduating from Harvard, Narasimhan joined McKinsey & Company, Inc. got included in. Later in 2005, Novartis approached him. He served as the Global Head of Development for Novartis Pharmaceuticals from 2014 to 2016. He served as the company’s chief medical officer and global head. Drug development from 2016 to 2018. He was selected on September 5, 2017 to replace Joseph Jimenez as the CEO of Novartis.
Novartis AG (Global Research) is a multinational pharmaceutical company with offices in Basel, Switzerland and Cambridge, Massachusetts, United States. The company is one of the largest in the pharmaceutical industry. Clozapine (marketed as Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (marketed as Tegretol), valsartan (marketed as Diovan), imatinib mesylate (as Gleevec/Gleevec) Cyclosporine (marketed as Neoral/Sandimmune), Letrozole (marketed as Femara), Methylphene
The businesses of Ciba-Geigy and Sandoz merged to form Novartis in March 1996. Novartis was formed as an independent company by the pharmaceutical and agrochemical divisions of the companies. Similar to Ciba Specialty Chemicals, the other Ciba-Gigi and Sandoz businesses were sold or closed as separate businesses. After being extinct for three years, the Sandoz brand was brought back in 2003 when Novartis merged its generic drug business into a single subsidiary and renamed it Sandoz.
Read more: Pat Gelsinger Bio, Age, Education, Wife, VMware, Christian, Net, Son Cancer, Intel CEO
In 2000, Novartis sold its agrochemical and genetically modified crop businesses after Syngenta was spun off into a joint venture with AstraZeneca, which had previously sold its agrochemical division. Novartis is a full member of the Pharmaceutical Research and Manufacturers of America (PhRMA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the European Federation of Pharmaceutical Industries and Associations (EFPIA).[5] (PHRMA).
